KEY DIAGNOSTICS BOOSTED IN ETHIOPIA – Multi-functional instruments land in Addis Ababa to bridge the gap
EINPresswire,
ADDIS ABABA, ETHIOPIA, October 7, 2021 /EINPresswire.com/ -- Roche Diagnostics, in collaboration with Retina Pharmaceuticals…
News story from Finanz Nachrichten on Thursday 05 August 2021
Finanz Nachrichten,
COMUNICADO: Mel-Mont Medical anuncia la validación de su tecnología patentada de automuestreo, Mia by XytoTest®
Notimerica,
-Mel-Mont Medical anuncia la validación de su tecnología patentada de automuestreo, Mia by XytoTest®, para el cribado molecular…
Mel-Mont Medical anuncia la validación de su tecnología patentada de automuestreo, Mia by XytoTest®
Europa Press,
-, para el cribado molecular con HPV-ADN y ARNm E6/E7 tipo 7 "Porque prevenir es posible" KLOKKARSTUA, Noruega, 4 de agosto de…
Mel-Mont Medical anuncia la validación de su tecnología patentada de autotoma de la muestra vaginal, Mía by XytoTest®, para el cribado molecular utilizando ADN-VPH y ARNm E6/E7 para 7 genotipos.
Bolsamanía,
Mel-Mont Medical anuncia la validación de su tecnología patentada de autotoma de la muestra vaginal, Mía by XytoTest®, para el…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Spoke,
"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…
News story from PR Newswire UK on Wednesday 04 August 2021
PR Newswire UK,
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Yahoo!,
"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Ticker Tech,
"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
WFMZ-TV 69,
KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device and technology company dedicated…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
PR Newswire,
"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Benzinga,
KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device and technology company dedicated…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Yahoo! Finance USA,
"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ Mel-Mont Medical, a boutique medical device and…
Mel-Mont Medical Announces The Validation Of Its Patented Self-sampling Technology, Mía By XytoTest®, For Molecular Screening Using HPV-DNA And 7-Type MRNA E6/E7.
The Street,
"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Morning Star,
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening…
Mel-Mont Medical anuncia la validación de su tecnología patentada de autotoma de la muestra vaginal, Mía by XytoTest®, para el cribado molecular utilizando ADN-VPH y ARNm E6/E7 para 7 genotipos.
Agencia EFE,
"Porque la prevención es posible" PR Newswire KLOKKARSTUA, Noruega, 4 de agosto de 2021 KLOKKARSTUA, Noruega, 4 de agosto de…